MedTrace Logo

Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients

NCT01477697 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-02-25

No results posted yet for this study

Summary

This study will evaluate the effects of omega-3 fatty acid supplementation on inflammation in trauma patients. The main hypothesis is that such supplementation will reduce the presence of biomarkers of systemic inflammation, as compared to placebo

Conditions

  • Multiple Trauma

Interventions

DIETARY_SUPPLEMENT

Omega-3

50 mg/kg per day of omega-3 fatty acids

DIETARY_SUPPLEMENT

Placebo

50 mg/kg per day of placebo equivalent

Sponsors & Collaborators

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Krishna Athota, MD · University of Cincinnati

  • Richard Branson, MSc · University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477697 on ClinicalTrials.gov